| [1] |
Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg, 2001, 234(4):507-517.
|
| [2] |
Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet, 1975, 140(2):170-178.
|
| [3] |
Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg, 1998, 228(3):385-394.
|
| [4] |
Manfredi R, Barbaro B, Masselli G, et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis, 2004, 24(2):155-164.
|
| [5] |
Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg, 2003, 238(1):73-83.
|
| [6] |
Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg, 2008, 248(2):273-279.
|
| [7] |
刘杰，姜洪池.肝门部胆管癌手术方式选择.国际外科学杂志, 2007, 34(6):429-431.
|
| [8] |
Hasegawa S, Ikai I, Fujii H, et al. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg, 2007, 31(6):1256-1263.
|
| [9] |
Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg, 2005, 241(5):703-712.
|
| [10] |
Ikeyama T, Nagino M, Oda K, et al. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg, 2007, 246(6):1052-1057.
|
| [11] |
Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg, 2001, 233(3):385-392.
|
| [12] |
胡文杰，梁力建.如何进一步提高肝门部胆管癌手术切除率及安全性.外科理论与实践, 2011, 16(4):340-343.
|
| [13] |
Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg, 2002, 137(6):675-680.
|
| [14] |
Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg, 2004, 139(5):514-523.
|
| [15] |
Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg, 1986, 10(5):803-808.
|
| [16] |
Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg, 2006, 243(3):364-372.
|
| [17] |
Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: curent management. Ann Surg, 2009, 250(2):210-218.
|
| [18] |
Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma. analysis of 100 patients. Ann Surg, 2002, 235(3):392-399.
|
| [19] |
Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc, 2006, 20(5):721-725.
|
| [20] |
彭淑牖，洪德飞.肝门部胆管癌根治性切除手术的规范化问题.中华外科杂志, 2009, 47(15):1123-1126.
|
| [21] |
Sakamoto Y, Shimada K, Nara S, et al. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg, 2010, 14(2):335-343.
|
| [22] |
姜洪池.微创化——外科学发展的不懈追求.中国实用外科杂志, 2004, 24(8):472-474.
|
| [23] |
姜洪池，孙备，王刚.浅谈微创观念指导下的精准肝切除.中华外科杂志, 2009, 47(21):1606-1609.
|